Novel 5,7-disubstituted [1, 3] thiazolo [4, 5] pyrimidin-2 (3H)-amine derivatives and their use in therapy

Details for Australian Patent Application No. 2007300749 (hide)

Owner AstraZeneca AB

Inventors Karlstrom, Sofia; Slivo, Can; Kers, Annika; Johansson, Rolf; Rein, Tobias; Nordvall, Gunnar

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2007300749

PCT Pub. Number WO2008/039139

Priority 60/828,122 04.10.06 US; 60/827,442 29.09.06 US

Filing date 27 September 2007

Wipo publication date 3 April 2008

Acceptance publication date 25 August 2011

International Classifications

C07D 513/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

7 May 2009 PCT application entered the National Phase

  PCT publication WO2008/039139 Priority application(s): WO2008/039139

25 August 2011 Application Accepted

  Published as AU-B-2007300749

22 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007300751-Chromatography ligand comprising Domain C from Staphyloccocus aureus protein A for antibody isolation

2007300748-Novel 5, 7-disubstituted [1, 3] thiazolo [4, 5-d] pyrimidin-2 (3H)-one derivatives and their use in therapy